These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 19306899
1. Penetration and efficacy of VEGF siRNA using polyelectrolyte complex micelles in a human solid tumor model in-vitro. Al-Abd AM, Lee SH, Kim SH, Cha JH, Park TG, Lee SJ, Kuh HJ. J Control Release; 2009 Jul 20; 137(2):130-5. PubMed ID: 19306899 [Abstract] [Full Text] [Related]
2. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. Kim SH, Jeong JH, Lee SH, Kim SW, Park TG. J Control Release; 2006 Nov 28; 116(2):123-9. PubMed ID: 16831481 [Abstract] [Full Text] [Related]
4. LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI. Kim SH, Jeong JH, Lee SH, Kim SW, Park TG. Bioconjug Chem; 2008 Nov 19; 19(11):2156-62. PubMed ID: 18850733 [Abstract] [Full Text] [Related]
5. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference. Wang J, Shi YQ, Yi J, Ye S, Wang LM, Xu YP, He M, Kong XM. J Dig Dis; 2008 Nov 19; 9(4):228-37. PubMed ID: 18959596 [Abstract] [Full Text] [Related]
6. Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma. Koldehoff M, Beelen DW, Elmaagacli AH. J Leukoc Biol; 2008 Aug 19; 84(2):561-76. PubMed ID: 18458152 [Abstract] [Full Text] [Related]
7. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression. Huang HY, Kuo WT, Chou MJ, Huang YY. J Biomed Mater Res A; 2011 Jun 01; 97(3):330-8. PubMed ID: 21465641 [Abstract] [Full Text] [Related]
8. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice. He XW, Yu X, Liu T, Yu SY, Chen DJ. Chin Med J (Engl); 2008 Mar 05; 121(5):439-44. PubMed ID: 18364118 [Abstract] [Full Text] [Related]
9. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Kim WJ, Christensen LV, Jo S, Yockman JW, Jeong JH, Kim YH, Kim SW. Mol Ther; 2006 Sep 05; 14(3):343-50. PubMed ID: 16765648 [Abstract] [Full Text] [Related]
10. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Zhu C, Jung S, Luo S, Meng F, Zhu X, Park TG, Zhong Z. Biomaterials; 2010 Mar 05; 31(8):2408-16. PubMed ID: 19963269 [Abstract] [Full Text] [Related]
11. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice. Murata N, Takashima Y, Toyoshima K, Yamamoto M, Okada H. J Control Release; 2008 Mar 20; 126(3):246-54. PubMed ID: 18215787 [Abstract] [Full Text] [Related]
13. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes. Kim SH, Lee SH, Tian H, Chen X, Park TG. J Drug Target; 2009 May 20; 17(4):311-7. PubMed ID: 19242850 [Abstract] [Full Text] [Related]
14. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma. Guo B, Zhang Y, Luo G, Li L, Zhang J. Anat Rec (Hoboken); 2009 May 20; 292(5):633-9. PubMed ID: 19382240 [Abstract] [Full Text] [Related]